Download
1423-0127-21-34.pdf 1,84MB
WeightNameValue
1000 Titel
  • SARS-CoV envelope protein palmitoylation or nucleocapid association is not required for promoting virus-like particle production
1000 Autor/in
  1. Tseng, Ying-Tzu |
  2. Wang, Shiu-Mei |
  3. Huang, Kuo-Jung |
  4. Wang, Chin-Tien |
1000 Erscheinungsjahr 2014
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2014-04-27
1000 Erschienen in
1000 Quellenangabe
  • 21(1):34
1000 Copyrightjahr
  • 2014
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/1423-0127-21-34 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014084/ |
1000 Ergänzendes Material
  • https://jbiomedsci.biomedcentral.com/articles/10.1186/1423-0127-21-34#Sec18 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Coronavirus membrane (M) proteins are capable of interacting with nucleocapsid (N) and envelope (E) proteins. Severe acute respiratory syndrome coronavirus (SARS-CoV) M co-expression with either N or E is sufficient for producing virus-like particles (VLPs), although at a lower level compared to M, N and E co-expression. Whether E can release from cells or E/N interaction exists so as to contribute to enhanced VLP production is unknown. It also remains to be determined whether E palmitoylation or disulfide bond formation plays a role in SARS-CoV virus assembly. RESULTS: SARS-CoV N is released from cells through an association with E protein-containing vesicles. Further analysis suggests that domains involved in E/N interaction are largely located in both carboxyl-terminal regions. Changing all three E cysteine residues to alanines did not exert negative effects on E release, E association with N, or E enhancement of VLP production, suggesting that E palmitoylation modification or disulfide bond formation is not required for SARS-CoV virus assembly. We found that removal of the last E carboxyl-terminal residue markedly affected E release, N association, and VLP incorporation, but did not significantly compromise the contribution of E to efficient VLP production. CONCLUSIONS: The independence of the SARS-CoV E enhancement effect on VLP production from its viral packaging capacity suggests a distinct SARS-CoV E role in virus assembly.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Severe Acute Respiratory Syndrome
lokal Release Capacity
lokal Carboxyl Terminus
lokal Infectious Bronchitis Virus
lokal Iodixanol
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/VHNlbmcsIFlpbmctVHp1|https://frl.publisso.de/adhoc/uri/V2FuZywgU2hpdS1NZWk=|https://frl.publisso.de/adhoc/uri/SHVhbmcsIEt1by1KdW5n|https://frl.publisso.de/adhoc/uri/V2FuZywgQ2hpbi1UaWVu
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6420383.rdf
1000 Erstellt am 2020-04-23T11:46:43.788+0200
1000 Erstellt von 122
1000 beschreibt frl:6420383
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet 2020-04-23T11:53:34.151+0200
1000 Objekt bearb. Thu Apr 23 11:51:04 CEST 2020
1000 Vgl. frl:6420383
1000 Oai Id
  1. oai:frl.publisso.de:frl:6420383 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source